Research ArticleClinical Studies

Gastrocutaneous Fistula in a Patient with Locally Recurrent MSI-High Colorectal Cancer: Local Complications Arising from Therapeutic Response to Immune Checkpoint Blockade

CLAIRE GREENE, ERIC K. NAKAKURA and ANDREW H. KO
Anticancer Research July 2017, 37 (7) 3679-3684;

Article Figures & Data

Figures

  • Figure 1.
    Figure 1.

    (A) Fungating chest wall mass prior to initiation of pembrolizumab. (B) Evidence of tumor necrosis following 2 cycles of treatment. (C) Chest wall cavity following tumor debridement, with gastrocutaneous fistula.

  • Figure 2.
    Figure 2.

    Cross-sectional imaging (CT scan with contrast) prior to start of pembrolizumab demonstrating large fungating mass centered in the left upper quadrant, lung base, and pleural space, in direct communication with the stomach and eroding through the left posterior chest wall.

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Gastrocutaneous Fistula in a Patient with Locally Recurrent MSI-High Colorectal Cancer: Local Complications Arising from Therapeutic Response to Immune Checkpoint Blockade
CLAIRE GREENE, ERIC K. NAKAKURA, ANDREW H. KO
Anticancer Research Jul 2017, 37 (7) 3679-3684;
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords